CymitQuimica logo
Stem Cell and Derivatives

Stem Cell and Derivatives

Stem cell inhibitors are compounds that specifically target signaling pathways and proteins involved in the maintenance, differentiation, and proliferation of stem cells. These inhibitors are crucial for understanding stem cell biology and for developing strategies to manipulate stem cells for therapeutic purposes, such as regenerative medicine and cancer treatment. By controlling stem cell fate, these inhibitors can help guide stem cell differentiation into specific cell types or prevent unwanted cell growth. At CymitQuimica, we offer a selection of high-quality stem cell inhibitors to support your research in stem cell biology, developmental biology, and regenerative medicine.

Subcategories of "Stem Cell and Derivatives"

Show 2 more subcategories

Found 681 products of "Stem Cell and Derivatives"

Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
products per page.
  • PROTAC YAP degrader-1


    <p>PROTAC YAP degrader-1, a targeted proteolysis promoting chimeric molecule, both degrades the YAP protein and inhibits its nuclear localization. This compound is formulated with Demethyl-NSC682769 as the target protein ligand, and utilizes (R,S,R)-AHPC-PEG2-C2-boc, which is the E3 ubiquitin ligase ligand + Linker conjugate. The linker incorporated in the design is Acid-PEG2-C2-Boc.</p>
    Formula:C56H62N6O9S
    Color and Shape:Solid
    Molecular weight:995.19
  • SJ10542

    CAS:
    SJ10542: potent JAK2/3-targeting PG-PROTAC; DC50s: JAK2 - 14 nM, JAK3 - 11 nM, JAK2-fusion ALL - 24 nM; CRBN recruiter.
    Formula:C41H46N12O5S
    Color and Shape:Solid
    Molecular weight:818.95
  • P17 Peptide

    CAS:
    <p>P17 Peptide, a human TGF-β1 inhibitory peptide, effectively blocks the activity of woodchuck TGF-β1.</p>
    Formula:C95H139N27O21
    Color and Shape:Solid
    Molecular weight:1995.29
  • CBT-295


    <p>CBT-295, an orally active autotaxin (ATX) inhibitor, effectively decreases inflammatory cytokines including TGF-β, TNF-α, and IL-6, along with the bile duct proliferation marker CK-19, and ameliorates liver fibrosis. The compound's ability to reverse liver fibrosis contributes to lowered ammonia levels in the blood and brain, which in turn reduces ammonia-induced neuroinflammation. CBT-295 shows potential for the study of liver cirrhosis and related encephalopathy.</p>
    Formula:C18H20ClN3O
    Color and Shape:Solid
    Molecular weight:329.82
  • FRM-024

    CAS:
    FRM-024 is a powerful gamma secretase modulator with the ability to penetrate the central nervous system (CNS), designed specifically for the treatment of
    Formula:C22H22ClN5O2
    Color and Shape:Solid
    Molecular weight:423.9
  • STAT3-IN-31


    <p>STAT3-IN-31 (compound K2071), derived from STATtic, acts as an inhibitor of both STAT3 and mitotic processes. This compound interrupts mitotic progression and impacts the formation of the mitotic spindle. Additionally, STAT3-IN-31 hampers migration in glioblastoma cells, suppresses cellular proliferation within tumor spheroids, induces senescence in glioblastoma, and inhibits the growth of Temozolomide-resistant cells while reducing the secretion of the pro-inflammatory cytokine monocyte chemoattractant protein (MCP-1).</p>
    Formula:C16H15NO3S
    Color and Shape:Solid
    Molecular weight:301.36
  • JAK1/STAT3-IN-1


    JAK1/STAT3-IN-1 (compound 4f) functions as an anti-atopic dermatitis (AD) agent by inhibiting the JAK1/STAT3 signaling pathway. It has an IC50 value of 2.17 μM for inhibiting NO production. Additionally, JAK1/STAT3-IN-1 improves skin conditions in AD-like mice by reducing inflammatory infiltration, suppressing the expression of p-JAK1/JAK1 and p-STAT3/STAT3, and alleviating the hyperimmune response induced by MC903 (Calcipotriol).
    Formula:C30H33FN4O3S
    Color and Shape:Solid
    Molecular weight:548.67
  • STAT3-IN-34


    <p>STAT3-IN-34 (Compound 15E) acts as a STAT3 inhibitor, blocking both the nuclear translocation and the transcriptional regulator activity of STAT3. It effectively inhibits HaCaT cell proliferation with an IC50 value of 0.008 μM. Additionally, STAT3-IN-34 reduces IL-17A expression and mitigates Imiquimod-induced psoriasis in mouse models.</p>
    Formula:C19H16N2O4S
    Color and Shape:Solid
    Molecular weight:368.41
  • YAP-IN-1


    YAP-IN-1 (Compound (+)-1) is an autophagy inhibitor specifically targeting YAP1. It binds to the Hippo pathway transcription factor YAP1 with a Kd of 9.13 μM, promoting its degradation through the chaperone-mediated autophagy (CMA) pathway. This process inhibits the Rab7-mediated fusion of autophagosomes with lysosomes and decreases autophagy levels without affecting lysosomal function. YAP-IN-1 shows potential for cancer research, including in hepatocellular carcinoma and breast cancer.
    Color and Shape:Odour Solid
  • TYD-68


    TYD-68 is a potent and selective CRBN-recruiting TYK2 PROTAC degrader, with a DC50 value of 0.42 nM. This compound effectively inhibits IL-12 and IFN-α-induced phosphorylation of STAT4 and STAT1, thereby blocking TYK2-dependent signaling pathways. TYD-68 is applicable in psoriasis research.
    Color and Shape:Odour Solid
  • WDR5 ligand 2

    CAS:
    <p>WDR5ligand 2 is a ligand for WDR5 and can be utilized in the synthesis of PROTAC WDR5degrader 1.</p>
    Formula:C29H31F3N4O4
    Color and Shape:Solid
    Molecular weight:556.576
  • ROCK2-IN-9


    ROCK2-IN-9 (compound 7u), a selective ROCK2 inhibitor with an IC50 value of 36.8 nM, demonstrates anticancer properties by impeding cancer cell migration and invasion. This action is achieved through the regulation of various actin cytoskeleton cellular activities. It holds potential for use in breast cancer research.
    Formula:C28H30N8O2
    Color and Shape:Solid
    Molecular weight:510.59
  • Notch 1 TFA


    Notch 1 TFA encodes a member of the NOTCH family of proteins.
    Formula:C64H98N15F3O25S3
    Purity:98%
    Color and Shape:Solid
    Molecular weight:1614.81
  • CIA-1 (Free base)

    CAS:
    CIA-1, a COUP-TFII inhibitor, has IC50 of 1.2-7.6 μM in prostate cancer cells; inhibits tumor growth in mouse prostate cancer.
    Formula:C17H19N3O2S
    Purity:99%
    Color and Shape:Solid
    Molecular weight:329.42
  • S-Ruxolitinib

    CAS:
    <p>S-Ruxolitinib can be used in related research in the field of life sciences. Its product number is T3066 and CAS number is 1160597-27-2.</p>
    Formula:C17H18N6
    Purity:98%
    Color and Shape:Solid
    Molecular weight:306.37
  • Axltide

    CAS:
    Axltide mimics mouse Insulin receptor substrate 1, amino acids 979-989 with sequence KKSRGDYMTMQIG.
    Formula:C63H107N19O20S2
    Purity:98%
    Color and Shape:Solid
    Molecular weight:1514.77
  • Tyrosine Protein Kinase JAK 2 (Phospho-Tyr8, 9)

    CAS:
    <p>Tyrosine Protein Kinase JAK 2 (Phospho-Tyr8, 9) is a peptide derived from mouse JAK2, specifically composed of amino acids 475 to 491.</p>
    Formula:C88H138N20O34P2
    Purity:98%
    Color and Shape:Solid
    Molecular weight:2082.1
  • SJ1008030 formic


    SJ1008030 (compound 8) formic is a selective JAK2 degrader within the PROTAC class, demonstrating efficacy in inhibiting MHH-CALL-4 leukemia cell growth with an
    Formula:C43H45N13O9S
    Purity:98%
    Color and Shape:Solid
    Molecular weight:919.96
  • PSEN1-IN-2


    PSEN1-IN-2 (Compound 13K) is a potent inhibitor of both PSEN1-APH1A and PSEN1-APH1B complexes, exhibiting IC50 values of 6.9 nM and 2.4 nM, respectively.
    Formula:C20H18ClFN2O3S
    Color and Shape:Solid
    Molecular weight:420.88
  • JAK3-IN-15


    JAK3-IN-15 (compound 22) is a JAK3 inhibitor that reduces the secretion of p-JAK3 induced by LPS. It is utilized in research for rheumatoid arthritis.
    Color and Shape:Odour Solid